Status:

RECRUITING

Clinical Prediction Model for In-Hospital Rebleeding in Acute Non-Variceal Upper Gastrointestinal Bleeding

Lead Sponsor:

Junwei Yan

Conditions:

Acute Non-variceal Upper Gastrointestinal Bleeding

Eligibility:

All Genders

18+ years

Brief Summary

ANVUGIB is a serious condition that can cause symptoms like vomiting blood or passing black stools. Although treatments have improved, about 10% to 30% of patients experience rebleeding shortly after ...

Eligibility Criteria

Inclusion Criteria:

  • age exceeding 18 years,
  • Clinical diagnosis of Acute Non-Variceal Upper Gastrointestinal Bleeding ,
  • patients who underwent endoscopy within 24 hours of admission with confirmation of non-variceal bleeding

Exclusion Criteria:

  • Upper Gastrointestinal Bleeding during hospitalization;
  • transfer from other hospitals;
  • variceal bleeding;
  • lower gastrointestinal bleeding.;
  • bleeding attributed to systemic diseases like disseminated intravascular coagulation (DIC) and hematological disorders;
  • patients with incomplete clinical data or laboratory test results;
  • patients who either requested early discharge or declined gastroscopy.

Key Trial Info

Start Date :

November 22 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06697691

Start Date

November 22 2024

End Date

December 1 2024

Last Update

November 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the Central Hospital of Wuhan

Wuhan, Hubei, China, 430000